| 1 |
32955700 | Interleukin-1β, interleukin-6, and interleukin-17A as indicators reflecting clinical response to celecoxib in ankylosing spondylitis patients. | 2021 May |
3 |
| 2 |
33672354 | Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory Drugs. | 2021 Feb 23 |
1 |
| 3 |
34445685 | A Combination of Celecoxib and Glucosamine Sulfate Has Anti-Inflammatory and Chondroprotective Effects: Results from an In Vitro Study on Human Osteoarthritic Chondrocytes. | 2021 Aug 20 |
1 |
| 4 |
32142484 | Prevention of Severe Acute Pancreatitis With Cyclooxygenase-2 Inhibitors: A Randomized Controlled Clinical Trial. | 2020 Mar |
1 |
| 5 |
31048000 | Evaluation of selective and non-selective cyclooxygenase inhibitors on sulfur mustard-induced pro-inflammatory cytokine formation in normal human epidermal keratinocytes. | 2019 Sep 15 |
1 |
| 6 |
31092431 | Nonsteroidal Anti-inflammatory Drugs Modulate Gene Expression of Inflammatory Mediators in Oral Squamous Cell Carcinoma. | 2019 May |
1 |
| 7 |
31123968 | Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblasts of patients with rheumatoid arthritis. | 2019 Dec |
2 |
| 8 |
29674687 | Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling. | 2018 Apr 19 |
1 |
| 9 |
28713941 | Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro. | 2017 Sep |
1 |
| 10 |
32185252 | In vivo study of pro-inflammatory cytokine changes in serum and synovial fluid during treatment with celecoxib and etoricoxib and correlation with VAS pain change and synovial membrane penetration index in patients with inflammatory arthritis. | 2017 Mar |
1 |
| 11 |
25201048 | Sphingosine-1-phosphate mediates COX-2 expression and PGE2 /IL-6 secretion via c-Src-dependent AP-1 activation. | 2015 Mar |
1 |
| 12 |
24296978 | Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib. | 2014 Feb |
8 |
| 13 |
23331485 | The anti-inflammatory effect of cyclooxygenase inhibitors in fibroblast-like synoviocytes from the human temporomandibular joint results from the suppression of PGE2 production. | 2013 Jul |
1 |
| 14 |
23817417 | Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase/prostaglandin E2 pathway, independent of IL-23. | 2013 Aug 1 |
1 |
| 15 |
22516310 | Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. | 2012 Dec 10 |
6 |
| 16 |
22644591 | Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application. | 2012 Sep |
2 |
| 17 |
21397587 | Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells. | 2011 Apr 15 |
1 |
| 18 |
21490132 | Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells. | 2011 Aug |
5 |
| 19 |
21733822 | Lung cancer chemoprevention with celecoxib in former smokers. | 2011 Jul |
1 |
| 20 |
17590218 | Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib. | 2007 Aug |
1 |
| 21 |
16190383 | [Significance and expression of cyclooxygenase-2 mRNA in peripheral blood monocytes in patients with acute coronary syndrome]. | 2005 Aug |
1 |
| 22 |
14711936 | Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting. | 2004 Mar |
1 |
| 23 |
11950021 | Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1beta and nonsteroidal antiinflammatory drugs. | 2002 Apr |
1 |